| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.009 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.009 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.01 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.01 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.3 | 0.02 |